Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neurobiology of Aging|April 21, 2006
Oxidative stress: a bridge between Down's syndrome and Alzheimer's diseaseMarianna Zana, Zoltán Janka, János Kálmán
Life Sciences|June 29, 2004
Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patientsJános Kálmán, Anna Juhász, Zoltán Rakonczay, et al.
Neurochemical Research|September 24, 2005
ApoE -491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia populationAnna Juhász, András Palotás, Zoltán Janka, et al.
Neurochemistry International|September 12, 2006
APP mRNA splicing is upregulated in the brain of biglycan transgenic miceAnnamária Bjelik, Magdolna Pákáski, Erika Bereczki, et al.
The International Journal of Neuropsychopharmacology|February 21, 2006
3,4-Methylenedioxymethamphetamine (MDMA), but not morphine, alters APP processing in the rat brainJános Kálmán, Annamária Bjelik, Marietta Hugyecz, et al.
Neurobiology of Aging|June 18, 2005
Alzheimer's lymphocytes are resistant to ultraviolet B-induced apoptosisMarianna Zana, Anna Juhász, Agnes Rimanóczy, et al.
Neurochemical Research|November 1, 2005
CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from HungaryAnna Juhász, Agnes Rimanóczy, Krisztina Boda, et al.
Neurochemistry International|March 21, 2006
Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosisAnnamária Bjelik, Erika Bereczki, Szilvia Gonda, et al.
Biochemical and Biophysical Research Communications|May 16, 2006
Age-dependent oxidative stress-induced DNA damage in Down's lymphocytesMarianna Zana, Anita Szécsényi, Agnes Czibula, et al.
Pageof 1